KYORIN Pharmaceutical Co., Ltd. (4569) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Suzuken Co., Ltd.

JCR Pharmaceuticals Co., Ltd.

Tsumura & Co.

Nippon Shinyaku Co., Ltd.

SAWAI GROUP HOLDINGS Co., Ltd.

Sumitomo Pharma Co., Ltd.

Mochida Pharmaceutical Co., Ltd.

Kaken Pharmaceutical Co., Ltd.

Nxera Pharma Co., Ltd.

Towa Pharmaceutical Co., Ltd.

KYORIN Pharmaceutical Co., Ltd.

Why is KYORIN Pharmaceutical Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of 4.62% and Operating profit at 17.27% over the last 5 years

NET SALES(HY) At JPY 67,526 MM has Grown at -9.9%
ROCE(HY) Lowest at 2.47%
INTEREST(Q) At JPY 70 MM has Grown at 18.64%

Consistent Underperformance against the benchmark over the last 3 years

Along with generating -23.47% returns in the last 1 year, the stock has also underperformed Japan Nikkei 225 in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is KYORIN Pharmaceutical Co., Ltd. for you?

Low Risk, Low Return

Absolute

Risk Adjusted

Volatility

KYORIN Pharmaceutical Co., Ltd.

-23.47%

-1.47

21.60%

Japan Nikkei 225

85.83%

3.09

27.80%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

4.62%

EBIT Growth (5y)

17.27%

EBIT to Interest (avg)

80.02

Debt to EBITDA (avg)

0.31

Net Debt to Equity (avg)

0.08

Sales to Capital Employed (avg)

0.80

Tax Ratio

28.85%

Dividend Payout Ratio

32.88%

Pledged Shares

Institutional Holding

0.11%

ROCE (avg)

5.21%

ROE (avg)

4.46%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.71

EV to EBIT

7.88

EV to EBITDA

5.93

EV to Capital Employed

0.74

EV to Sales

0.83

PEG Ratio

0.04

Dividend Yield

ROCE (Latest)

9.34%

ROE (Latest)

7.84%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Mildly Bullish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company

DIVIDEND PER SHARE(HY)

Highest at JPY 2.66

-31What is not working for the Company

NET SALES(HY)

At JPY 67,526 MM has Grown at -9.9%

ROCE(HY)

Lowest at 2.47%

INTEREST(Q)

At JPY 70 MM has Grown at 18.64%

DIVIDEND PAYOUT RATIO(Y)

Lowest at 0%

RAW MATERIAL COST(Y)

Grown by 30.65% (YoY

PRE-TAX PROFIT(Q)

Lowest at JPY -1,073 MM

NET PROFIT(Q)

Lowest at JPY -671 MM

EPS(Q)

Lowest at JPY -11.68

Here's what is working for KYORIN Pharmaceutical Co., Ltd.

Dividend per share

Highest at JPY 2.66

in the last five years

MOJO Watch

Company is distributing higher dividend from profits generated

DPS (JPY)

Depreciation

Highest at JPY 1,218 MM

in the last five periods

MOJO Watch

The expenditure on assets done by the company may have gone into operation

Depreciation (JPY MM)

Here's what is not working for KYORIN Pharmaceutical Co., Ltd.

Pre-Tax Profit

At JPY -1,073 MM has Fallen at -128.85%

over average net sales of the previous four periods of JPY 3,719.5 MM

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (JPY MM)

Net Profit

At JPY -671 MM has Fallen at -124.66%

over average net sales of the previous four periods of JPY 2,721.35 MM

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (JPY MM)

Interest

At JPY 70 MM has Grown at 18.64%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (JPY MM)

Net Sales

At JPY 67,526 MM has Grown at -9.9%

Year on Year (YoY)

MOJO Watch

Near term sales trend is negative

Net Sales (JPY MM)

Pre-Tax Profit

Lowest at JPY -1,073 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (JPY MM)

Net Profit

Lowest at JPY -671 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is negative

Net Profit (JPY MM)

EPS

Lowest at JPY -11.68

in the last five periods

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (JPY)

Dividend Payout Ratio

Lowest at 0%

in the last five years

MOJO Watch

Company is distributing lower proportion of profits generated as dividend

DPR (%)

Raw Material Cost

Grown by 30.65% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales